Can I take two 0.25mg Wegovy doses instead of one?

Wegovy is licensed as a single weekly subcutaneous injection at your prescribed dose — not two injections in the same week at any strength.
The 0.25mg starting dose exists to help your body adjust gradually; it is not a therapeutic minimum you can double to reach a target faster.
Taking more than your prescribed dose increases the likelihood of nausea, vomiting and other gastrointestinal side effects without evidence of additional benefit at that stage of treatment.
Any change to your Wegovy dose must be decided by a GPhC-registered prescriber who has reviewed your full clinical picture.

No — taking two 0.25mg Wegovy doses in a single week is not safe and not how the medicine is licensed. Wegovy is prescribed as one injection weekly, at the dose your prescriber has set. The 0.25mg starting dose is deliberately low; doubling it does not speed up weight loss, but it does raise your risk of side effects. This is a prescription-only medicine, and every dose adjustment has to go through your prescriber, not your own maths. If you have questions about whether your current dose is right for you, that is exactly the conversation to have with the clinician who prescribed it.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why doubling a 0.25mg dose seems logical but creates real problems

The decision you are probably weighing up

Most people who search this question are not trying to cut corners. They are frustrated. Progress on the starting dose feels slow, or they have missed a week and are wondering whether two injections back-to-back would help them catch up. Those are understandable instincts. The trouble is that Wegovy's dosing schedule is built around your body's tolerance, not simply around how much semaglutide a given weight needs. Altering the schedule yourself introduces risks that your prescriber is specifically there to manage.

The NHS medicines page for semaglutide is clear that you should use Wegovy exactly as directed and take each injection on the same day each week. If you miss a dose, the guidance is to inject as soon as you remember, provided your next scheduled dose is still more than five days away. If it is closer than that, you skip the missed dose entirely and continue on your normal day. Our page on whether you can take two doses of Wegovy explains in full why two injections close together is not a recommended catch-up strategy under any circumstance.

It is worth spending one minute before each injection checking the date of your last injection in your notes app or on the pen's own label. That small habit removes a lot of the confusion that leads people here.

What the 0.25mg dose is actually doing in your body

Semaglutide is a GLP-1 receptor agonist. At 0.25mg, it is not yet delivering the appetite-reducing effect that makes Wegovy effective for weight management, that comes as the dose is titrated upward over several months, typically moving through 0.5mg, 1mg and 1.7mg before reaching the standard 2.4mg maintenance dose, with a minimum of roughly four weeks at each level. The full Wegovy dosing schedule explains the progression in practical terms.

The reason the titration is slow is physiological. Semaglutide slows how quickly your stomach empties, which is part of how it reduces hunger. Moving too quickly through doses, or taking more than prescribed at any single point, overloads that mechanism and produces nausea, vomiting and diarrhoea that can be severe enough to stop treatment altogether. Doubling your 0.25mg dose to 0.5mg in a single week (which is effectively what two injections would do) bypasses the graduated adjustment your prescriber has planned.

There is no clinical evidence that accelerating the titration by taking two starter doses produces faster weight loss. The STEP 1 trial, which produced the results underpinning Wegovy's licence, was conducted on the standard titration schedule across 68 weeks. Those are the conditions under which the medicine's safety and effectiveness were established.

What to do instead of a second injection

If you feel the 0.25mg dose is not working, or you have missed an injection and are unsure how to proceed, the right move is to contact whoever prescribed it. That is not a bureaucratic hurdle, it is the point. A prescriber can look at your full picture, assess whether a dose increase is appropriate, and advise on the safest way to handle a missed week. You can also read the practical guide to taking Wegovy doses for general handling advice, though any personalised timing question belongs with your clinician.

On cost, some people consider doubling a dose because they want to use up a pen that has doses remaining. The Wegovy pricing page gives honest context on what private treatment typically costs month by month, and if you are moving through the schedule and wondering what the next tier involves, our guide to the 4.8mg Wegovy dose covers that stage in detail. It is always cheaper, in the long run, to use the medicine as prescribed rather than risk a side-effect episode that disrupts treatment entirely.

If you are looking at Wegovy for the first time and wondering how the starting process works in practice, the guide to the first Wegovy injection covers what to expect from the 0.25mg stage. And if you are curious about how Wegovy compares to other treatment options, the weight-loss treatment overview sets out the full landscape clearly.

When to speak to someone urgently

If you have already taken two doses close together and are experiencing symptoms, this matters. Gastrointestinal effects like nausea and vomiting are the most likely outcome; stay hydrated and contact your prescriber or GP. Seek urgent medical attention for severe, persistent stomach pain that radiates to the back, with or without vomiting, as this can be a sign of pancreatitis. The MHRA highlighted acute pancreatitis as a known, though infrequent, serious risk with GLP-1 medicines in a January 2026 safety update, it is rare, but it is not something to wait out at home.

You can report any suspected side effects to the MHRA via the Yellow Card reporting scheme. For questions about your own treatment, your prescriber is the first call. If you are not currently on Wegovy and are considering whether it might suit you, checking your eligibility through a free consultation is the right starting point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions